Radiotherapy Market to grow by USD 12.2 billion by 2033, Globally at 5.9% CAGR | Market.us
29 janv. 2024 07h10 HE
|
Market.Us
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global radiotherapy market size is forecasted to exceed USD 12.2 billion by 2033, with a promising CAGR of 5.9% from 2024 to...
Photodynamic Therapy Market Set to Hit USD 5.53 Billion by 2033 | Boosting Opportunities for Medical Innovations
18 janv. 2024 06h51 HE
|
Market.Us
New York, Jan. 18, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Photodynamic therapy market size is projected to surpass around USD 5.53 Billion by 2033, and it is poised to reach a...
Multi-Cancer Early Detection Market Size to Reach US$2.5 Bn by 2030, Fairfield Market Research Indicates Europe’s Leadership
13 déc. 2023 08h56 HE
|
Fairfield Consultancy Services OPC Pvt Ltd
London, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The global multi-cancer early detection market, presently valued at approximately US$0.89 Bn, is projected to witness an impressive CAGR of 16.3% through...
Sermonix Pharmaceuticals Shares Pharmacokinetic and Baseline Genomic Clinical Data Tied to ELAINE Lasofoxifene Trials of Patients With ESR1 Mutations
12 déc. 2023 09h00 HE
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology
11 déc. 2023 09h00 HE
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
TeleDaaS™ Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations
26 nov. 2023 08h00 HE
|
TeleDaas PLLC
TeleDaaS revolutionizes radiopharmaceutical research by delivering highly-scalable, clinical-grade dosimetry to accelerate cancer treatment breakthroughs.
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
09 nov. 2023 21h49 HE
|
Turnstone Biologics Corp.
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
30 oct. 2023 06h00 HE
|
Turnstone Biologics Corp.
Internationally recognized cancer immunotherapy thought leader, Dr. Weber, will help guide Turnstone’s continued advancement of its Selected TIL therapies
Neoantigen Cancer Vaccine Market Size is Projected to Reach $1.38 billion by 2030: Straits Research
26 oct. 2023 15h00 HE
|
Straits Research
New York, United States, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Neoantigens that arise from cancer-specific mutations are an additional class of antigens that are desirable for therapeutic cancer...
Andira Pharmaceuticals Achieves Remarkable Breast Cancer Tumor Regression with Lead Oncology Candidate XOXO4
25 oct. 2023 13h20 HE
|
US Capital Global
San Francisco, California, USA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, recently launched an investment opportunity of up to $5 million...